The blog
Clinical trial results, TGA regulatory progress and research updates on retatrutide and the wider peptide space — explained for Australians.
29 September 2026 · nad-plus · nmn · research · australia · regulation
NAD+ research update: a 2026 meta-analysis of 10 NMN trials found 2.15 mmHg off diastolic BP, but nothing for muscle. Plus NMN Australia TGA rules.
Read more →26 September 2026 · nad-plus · nmn · nicotinamide-riboside · research · tga
Two 2026 NAD+ trials, two headlines: a 65-person NR vs NMN comparison and a 6-person PK study. What the evidence shows and the TGA rules in Australia.
Read more →23 September 2026 · nad-plus · nmn · nicotinamide-riboside · gut-microbiome · tga
New NAD+ research suggests gut bacteria convert NMN and NR into nicotinic acid. What the 65-person trial showed, and NMN's legal status in Australia.
Read more →20 September 2026 · nad-plus · nmn · nicotinamide-riboside · research · tga
NAD+ research 2026: blood NAD rose within days but brain NAD only after 4 weeks in a phase I trial. What that means for NMN, NR and TGA rules in Australia.
Read more →18 September 2026 · nad-plus · nmn · nicotinamide-riboside · research · tga
A 2026 head-to-head trial found NMN and NR doubled blood NAD+ in 14 days. Australian rules bar any "boosts NAD+" claim. The NAD+ research, checked.
Read more →15 September 2026 · nad-plus · nmn · nicotinamide-riboside · tga · longevity
NAD+ IV drips are everywhere, but is NAD+ legal in Australia and does the research hold up? The 2026 IV trials, TGA status and what the NR data show.
Read more →12 September 2026 · nad-plus · nmn · nicotinamide-riboside · research · tga
Two 2026 trials compared NMN, NR and nicotinamide head-to-head. What the NAD+ research really shows, the gut-microbe twist, and the rules in Australia.
Read more →9 September 2026 · nad-plus · nmn · nicotinamide-riboside · longevity · tga
NAD+ research in 2026: a 113-study review found NMN and NR reliably raise NAD+ levels, but functional outcomes stay mixed. Plus the NAD+ Australia TGA rules.
Read more →Stay informed
Retatrutide is not yet available to the public. But when it is, you will want to be first to know. Sign up to receive:
Get the free guide + updates
Enter your details once on our free access guide page — instant download, plus we'll email you the moment there's real news.